title: Acute retinal toxicity from the novel anti-tumor agent, Irofulven.
authors.affiliation: Department of Ophthalmology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA.
authors.forename: Robert F
authors.initials: RF
authors.lastname: Melendez
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Harrison
authors.forename: Eric K
authors.initials: EK
authors.lastname: Rowinsky
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Hammond
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Fitzsimmons
mesh_terms: D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D004596:Electroretinography; D005074:Evoked Potentials, Visual; D005260:Female; D006801:Humans; D008875:Middle Aged; D012160:Retina / Q000187:drug effects* / Q000503:physiopathology; D012164:Retinal Diseases / Q000139:chemically induced* / Q000503:physiopathology; D012717:Sesquiterpenes / Q000009:adverse effects*; D014794:Visual Fields / Q000187:drug effects
chemical_list: D018906:Antineoplastic Agents, Alkylating; D012717:Sesquiterpenes; C102714:irofulven